» Articles » PMID: 35957758

Impact of Weight Loss on the Severity of Albuminuria in Obese Diabetic Patients Undergoing Laparoscopic Sleeve Gastrectomy and One-Anastomosis Gastric Bypass

Overview
Journal Int J Gen Med
Publisher Dove Medical Press
Specialty General Medicine
Date 2022 Aug 12
PMID 35957758
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To examine the effect of weight-loss induced bariatric procedures on albuminuria levels among diabetic patients suffering from obesity.

Methods: Adults patients who suffer from morbid obesity and type 2 diabetes mellitus (T2DM) were included in a prospective cohort study. Subjects were scheduled to undergo laparoscopic sleeve gastrectomy (LSG) or one-anastomosis gastric bypass (OAGB). The albumin-to-creatinine ratio (ACR) was adopted to assess the degree of albuminuria. Microalbuminuria was determined as a ratio of >2.5-30 mg/mmol and >3.5-30 mg/mmol for males and females, respectively, while macroalbuminuria was diagnosed when the ACR exceeded >30 mg/mmol.

Results: The mean uACR decreased significantly from 20.95±16.89 to 9.92±12.69mg/mmol in LSG cohort (p <0.001), and from 19.52±16.65 to 9.34±11.77mg/mmol in the OAGB cohort, with no statistically considerable differences between both cohorts at the end of follow-up (p = 0.78). Twelve months after the procedures, the percentages of cases with microalbuminuria decreased significantly to 23.8% and 23.9%, respectively (p < 0.001); likewise, the percentages of cases with macroalbuminuria significantly decreased to 7.9% and 7.5% in the LSG and OAGB groups, respectively (p < 0.001). There were no statistically considerable differences between LSG and OAGB regarding the percentages of patients with micro or macroalbuminuria at the end of follow-up. Besides, there were no significant associations between the degree of weight loss and improvement (p = 0.959) or remission (p = 0.73) of microalbuminuria.

Conclusion: Bariatric surgery significantly reduced the severity of albuminuria 1-year after the procedure, with no preference for one procedure over the other.

Citing Articles

The Impact of Bariatric Surgery on Type 2 Diabetes Mellitus Remission: A Systematic Review.

Mohamed A, Aljabal H, Alalawi A, Al-Nooh N Cureus. 2024; 16(11):e74755.

PMID: 39735002 PMC: 11682853. DOI: 10.7759/cureus.74755.


The Impact of Metabolic and Bariatric Surgery on Diabetic Kidney Disease in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis.

Einafshar N, Esparham A, Moghani M, Radboy M, Ghamari M, Zandbaf T Obes Surg. 2024; 35(1):329-340.

PMID: 39656373 DOI: 10.1007/s11695-024-07612-8.


Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study.

Garcia de Lucas M, Caballero I, Fernandez-Garcia J, Dominguez-Rodriguez M, Moreno-Moreno P, Jimenez-Millan A Front Endocrinol (Lausanne). 2023; 14:1240279.

PMID: 37955013 PMC: 10634592. DOI: 10.3389/fendo.2023.1240279.

References
1.
Coresh J, Astor B, Greene T, Eknoyan G, Levey A . Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002; 41(1):1-12. DOI: 10.1053/ajkd.2003.50007. View

2.
Rao S . Inflammatory markers and bariatric surgery: a meta-analysis. Inflamm Res. 2012; 61(8):789-807. DOI: 10.1007/s00011-012-0473-3. View

3.
Hafida S, Mirshahi T, Nikolajczyk B . The impact of bariatric surgery on inflammation: quenching the fire of obesity?. Curr Opin Endocrinol Diabetes Obes. 2016; 23(5):373-8. PMC: 5067163. DOI: 10.1097/MED.0000000000000277. View

4.
Baskota A, Li S, Dhakal N, Liu G, Tian H . Bariatric Surgery for Type 2 Diabetes Mellitus in Patients with BMI <30 kg/m2: A Systematic Review and Meta-Analysis. PLoS One. 2015; 10(7):e0132335. PMC: 4500506. DOI: 10.1371/journal.pone.0132335. View

5.
Jauregui A, Mintz D, Mundel P, Fornoni A . Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria. Curr Opin Nephrol Hypertens. 2009; 18(6):539-45. PMC: 2907246. DOI: 10.1097/MNH.0b013e32832f7002. View